Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey | Zendy

Aline Umubyeyi | Zendy; Leen Rigouts | Zendy; Isdore Chola Shamputa | Zendy; K. Fissette | Zendy; Y. Elkrim | Zendy; P. W. B. de Rijk | Zendy; Marc Struelens | Zendy; Françoise Portaels | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey

Author(s) -

Aline Umubyeyi,

Leen Rigouts,

Isdore Chola Shamputa,

K. Fissette,

Y. Elkrim,

P. W. B. de Rijk,

Marc Struelens,

Françoise Portaels

Publication year - 2007

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkm038

Subject(s) - ofloxacin , mycobacterium tuberculosis , tuberculosis , antibiotics , microbiology and biotechnology , drug resistance , medicine , antibacterial agent , multiple drug resistance , virology , biology , ciprofloxacin , pathology

There is an increasing interest in the possible role of fluoroquinolone antibiotics for the treatment of tuberculosis (TB), but widespread use of these antibiotics for the treatment of other bacterial infections may select for fluoroquinolone-resistant Mycobacterium tuberculosis strains.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research